Beihai Gofar Marine Biological Industry Co Ltd (600538) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-10.30 Million ≈ $-1.51 Million USD) by net assets (CN¥785.32 Million ≈ $114.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beihai Gofar Marine Biological Industry Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Beihai Gofar Marine Biological Industry balance sheet liabilities for a breakdown of total debt and financial obligations.
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wildcat Resources Ltd
AU:WC8
|
-0.002x |
|
Malam Team
TA:MLTM
|
0.085x |
|
Hunan Sundy Science and Technology Co Ltd
SHE:300515
|
0.105x |
|
Tianjin Jinbin Development
SHE:000897
|
0.007x |
|
Nepes Corporation
KQ:033640
|
0.041x |
|
i3 Verticals Inc
NASDAQ:IIIV
|
0.029x |
|
Hunan Hansen Pharmaceutical Co Ltd
SHE:002412
|
0.023x |
|
China Chippacking Technology Co. Ltd. A
SHG:688216
|
N/A |
Annual Cash Flow Conversion Efficiency for Beihai Gofar Marine Biological Industry Co Ltd (2001–2024)
The table below shows the annual cash flow conversion efficiency of Beihai Gofar Marine Biological Industry Co Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see 600538 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥787.39 Million ≈ $115.22 Million |
CN¥1.95 Million ≈ $285.10K |
0.002x | +112.11% |
| 2023-12-31 | CN¥879.30 Million ≈ $128.67 Million |
CN¥-17.97 Million ≈ $-2.63 Million |
-0.020x | -24.61% |
| 2022-12-31 | CN¥959.98 Million ≈ $140.48 Million |
CN¥-15.74 Million ≈ $-2.30 Million |
-0.016x | -138.70% |
| 2021-12-31 | CN¥922.61 Million ≈ $135.01 Million |
CN¥-6.34 Million ≈ $-927.46K |
-0.007x | -121.79% |
| 2020-12-31 | CN¥851.56 Million ≈ $124.61 Million |
CN¥26.84 Million ≈ $3.93 Million |
0.032x | +473.92% |
| 2019-12-31 | CN¥645.61 Million ≈ $94.47 Million |
CN¥-5.44 Million ≈ $-796.48K |
-0.008x | +84.07% |
| 2018-12-31 | CN¥637.56 Million ≈ $93.30 Million |
CN¥-33.75 Million ≈ $-4.94 Million |
-0.053x | -196.61% |
| 2017-12-31 | CN¥659.18 Million ≈ $96.46 Million |
CN¥36.12 Million ≈ $5.29 Million |
0.055x | +302.99% |
| 2016-12-31 | CN¥688.79 Million ≈ $100.79 Million |
CN¥-18.59 Million ≈ $-2.72 Million |
-0.027x | -204.70% |
| 2015-12-31 | CN¥737.84 Million ≈ $107.97 Million |
CN¥-6.54 Million ≈ $-956.52K |
-0.009x | +84.25% |
| 2014-12-31 | CN¥729.59 Million ≈ $106.76 Million |
CN¥-41.05 Million ≈ $-6.01 Million |
-0.056x | -26.81% |
| 2013-12-31 | CN¥111.53 Million ≈ $16.32 Million |
CN¥-4.95 Million ≈ $-724.11K |
-0.044x | +83.13% |
| 2012-12-31 | CN¥91.60 Million ≈ $13.40 Million |
CN¥-24.09 Million ≈ $-3.52 Million |
-0.263x | -215.90% |
| 2011-12-31 | CN¥191.61 Million ≈ $28.04 Million |
CN¥-15.95 Million ≈ $-2.33 Million |
-0.083x | -27.56% |
| 2010-12-31 | CN¥225.47 Million ≈ $32.99 Million |
CN¥-14.71 Million ≈ $-2.15 Million |
-0.065x | -514.62% |
| 2009-12-31 | CN¥207.37 Million ≈ $30.34 Million |
CN¥-2.20 Million ≈ $-322.18K |
-0.011x | -119.93% |
| 2008-12-31 | CN¥325.43 Million ≈ $47.62 Million |
CN¥17.34 Million ≈ $2.54 Million |
0.053x | -38.36% |
| 2007-12-31 | CN¥492.89 Million ≈ $72.13 Million |
CN¥42.60 Million ≈ $6.23 Million |
0.086x | -51.04% |
| 2006-12-31 | CN¥529.39 Million ≈ $77.47 Million |
CN¥93.45 Million ≈ $13.67 Million |
0.177x | +3215.25% |
| 2005-12-31 | CN¥551.30 Million ≈ $80.67 Million |
CN¥2.94 Million ≈ $429.53K |
0.005x | -53.20% |
| 2004-12-31 | CN¥522.14 Million ≈ $76.41 Million |
CN¥5.94 Million ≈ $869.21K |
0.011x | +1364.46% |
| 2003-12-31 | CN¥478.86 Million ≈ $70.07 Million |
CN¥-430.83K ≈ $-63.04K |
-0.001x | -100.78% |
| 2002-12-31 | CN¥147.53 Million ≈ $21.59 Million |
CN¥17.01 Million ≈ $2.49 Million |
0.115x | -35.72% |
| 2001-12-31 | CN¥130.15 Million ≈ $19.05 Million |
CN¥23.35 Million ≈ $3.42 Million |
0.179x | -- |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly… Read more